$3.51 -$0.29 (-7.6%)

04:15 PM EST on 01/27/20

Protalix Biotherapeutics Inc (NYSEMKT:PLX)

CAPS Rating: No stars

A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system.

Current Price $3.51 Mkt Cap $52.1M
Open $0.00 P/E Ratio 0.00
Prev. Close $3.51 Div. (Yield) $0.00 (0.0%)
Daily Range $0.00 - $0.00 Volume 53,007
52-Wk Range $3.31 - $4.82 Avg. Daily Vol. 163,911

Caps

How do you think NYSEMKT:PLX will perform against the market?

Add Stock to CAPS Watchlist

All Players

146 Outperform
72 Underperform
 

All-Star Players

9 Outperform
22 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSEMKT:PLX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Paul8888888 (< 20)
Submitted January 23, 2016

It is outperforming the market. Volume low. Nobody is panicking.

TMFBiologyFool (76.94)
Submitted May 02, 2012

Low patient numbers + 2 competitors = tough launch.I actually like the manufacturing technology, but next drug is still years away.

NYSEMKT:PLX VS S&P 500 (SPY)

Fools bullish on NYSEMKT:PLX are also bullish on:

Fools bearish on NYSEMKT:PLX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about PLX.

Recs

1
Member Avatar Paul8888888 (< 20) Submitted: 1/23/2016 2:31:12 PM : Outperform Start Price: $0.86 NYSE MKT:PLX Score: +236.34

It is outperforming the market. Volume low. Nobody is panicking.

Recs

0
Member Avatar SqwiiTrader (< 20) Submitted: 11/5/2013 2:56:24 PM : Outperform Start Price: $4.40 NYSE MKT:PLX Score: -103.55

IHS pattern

Recs

1
Member Avatar TMFBiologyFool (76.94) Submitted: 5/2/2012 12:24:24 PM : Underperform Start Price: $7.02 NYSE MKT:PLX Score: +180.83

Low patient numbers + 2 competitors = tough launch.

I actually like the manufacturing technology, but next drug is still years away.

Leaderboard

Find the members with the highest scoring picks in PLX.

Score Leader

midastouch017

midastouch017 (35.72) Score: +803.98

For those who believe the biosimilar sector will enjoy a robust bright future, PLX is a wise bet

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
beecha < 20 9/19/2017 Outperform 5Y $0.60 +483.06% +29.48% +453.57 0 Comment
portefeuille3 97.19 12/27/2017 Outperform 5Y $0.66 +433.27% +21.03% +412.24 0 Comment
Spelunkin 90.93 11/3/2009 Underperform 5Y $10.39 -66.22% +212.04% +278.26 0 Comment
anticitrademix2 < 20 11/2/2009 Underperform 5Y $9.90 -64.55% +210.87% +275.42 0 Comment
anticitrademix < 20 11/2/2009 Underperform 5Y $9.90 -64.55% +210.87% +275.42 0 Comment
TrackDuality < 20 11/6/2009 Underperform 5Y $11.89 -70.48% +204.64% +275.12 0 Comment
MSFOBV1YH 99.35 11/4/2009 Underperform 5Y $10.93 -67.89% +206.81% +274.69 0 Comment
ModernDayWarrior 32.95 10/29/2009 Underperform 5Y $9.58 -63.36% +207.74% +271.10 0 Comment
39272x4 24.51 11/9/2009 Underperform 5Y $12.00 -70.75% +199.87% +270.62 0 Comment
mathieugp 26.21 9/28/2009 Underperform 3M $7.87 -55.40% +208.74% +264.14 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PLX.